Scientists test 'Drug-Resistant' immune cells to fight deadly brain tumor
NCT ID NCT04165941
Summary
This early-stage study is testing the safety of a new cell therapy for adults with a newly diagnosed, aggressive brain cancer called glioblastoma. Researchers are modifying a patient's own immune cells to resist chemotherapy, then injecting them directly into the brain alongside standard treatment. The main goal is to see if this combined approach is safe and to find the best dose, while also checking if it helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Conditions
Explore the condition pages connected to this study.